Hematolojik Malignitelerde Kemoterapi Protokolleri
ISBN 978-605-68222-4-7

KEMOTERAPİ İLE İLGİLİ GENEL BİLGİLER

Kaynaklar:

1-DeVita VT. The evolution of therapeutic research in cancer. N Engl J Med. 1978 Apr 20;298(16):907-10.

2-DeVita VT, Chu E. A history of cancer chemotherapy. Cancer Res. 2008 Nov 01;68(21):8643-53

3-Wochna Loerzel V. (2015). Symptom Experience in Older Adults Undergoing Treatment for Cancer. Oncol Nurs Forum, 42(3): E269–78. 

4-Russo S, Cinausero M, Gerratana L, et al. (2014). Factors affecting patient’s perception of anti-cancer treatments side-effects: an observational study. Expert Opin Drug Saf, 13(2): 139–50.

5-Moradian S, Howell D. (2015). Prevention and management of chemotherapy-induced nausea and vomiting. Int J Palliat Nurs, 21(5):216, 218–24.

6-Knoepfler PS. Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine. Stem cells 27(5): 1050-1056. 

7-Drusano GL. Antimicrobial pharmacodynamics: critical interactions of’ bug and drug. Nat Rev Microbiol 2(4): 289-300. 

8-Ferrara N, Kerbel RS. Angiogenesis as a therapeutic target. Nature 438(7070): 967-974. 

9-Conklin KA. Dietary antioxidants during cancer chemotherapy: impact on chemotherapeutic effectiveness and development of side effects. Nutr Cancer 37(1): 1-8. 5. 

10-Wang S, Placzek WJ, Stebbins JL, Mitra S, Noberini R, et al. (2012) Novel targeted system to deliver chemotherapeutic drugs to EphA2- expressing cancer cells. J Med Chem 55(5): 2427-2436.